{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:00:08Z","timestamp":1786993208620,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jpba.2019.05.062","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:26:38Z","timestamp":1559042798000},"page":"270-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Validation of an LC-MS\/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions"],"prefix":"10.1016","volume":"174","author":[{"given":"Christina","family":"Grumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Henkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Stratford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Hermanns-Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Passie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1883-2804","authenticated-orcid":false,"given":"Volker","family":"Auw\u00e4rter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2019.05.062_bib0005","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/dta.1884","article-title":"Return of the lysergamides. Part I: analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)","volume":"8","author":"Brandt","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.05.062_bib0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/dta.1985","article-title":"Return of the lysergamides. Part II: analytical and behavioural characterization of N(6)-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2\u2032S,4\u2032S)-lysergic acid 2,4-dimethylazetidide (LSZ)","volume":"9","author":"Brandt","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.05.062_bib0015","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/dta.2196","article-title":"Return of the lysergamides. Part III: analytical characterization of N(6)-ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD)","volume":"9","author":"Brandt","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.05.062_bib0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/dta.2222","article-title":"Return of the lysergamides. Part IV: analytical and pharmacological characterization of lysergic acid morpholide (LSM-775)","volume":"10","author":"Brandt","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.05.062_bib0025","article-title":"Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)","author":"Halberstadt","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpba.2019.05.062_bib0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2019.05.062_bib0035","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1520\/JFS16192J","article-title":"Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the zymark RapidTrace\u2122 with LC\/MS\/MS confirmation","volume":"43","author":"de Kanel","year":"1998","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jpba.2019.05.062_bib0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/jat\/22.6.520","article-title":"Stability study of LSD under various storage conditions","volume":"22","author":"Li","year":"1998","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2019.05.062_bib0045","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/clinchem\/48.9.1615","article-title":"Short-term stability of lysergic acid diethylamide (LSD), N-Desmethyl-LSD, and 2-Oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography\u2013tandem mass spectrometry","volume":"48","author":"Skopp","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2019.05.062_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/12.1.1","article-title":"Determination of LSD in urine by capillary column gas chromatography and electron impact mass spectrometry","volume":"12","author":"Francom","year":"1988","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2019.05.062_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0379-0738(97)00063-7","article-title":"Gas chromatographic\/mass spectrometric determination of lysergic acid diethylamide (LSD) in serum samples","volume":"88","author":"Musshoff","year":"1997","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2019.05.062_bib0060","first-page":"185","article-title":"Appendix B to the GTFCh Guidelines for quality assurance in forensic-toxicological analyses requirements for the validation of analytical methods","volume":"76","author":"Peters","year":"2009","journal-title":"Toxichem Krimtech"},{"key":"10.1016\/j.jpba.2019.05.062_bib0065","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2019.05.062_bib0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/dta.2042","volume":"9","author":"Steuer","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2019.05.062_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22265","article-title":"Development and validation of an LC-MS\/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial","volume":"32","author":"Dolder","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jpba.2019.05.062_bib0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpba.2015.07.001","article-title":"Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS\/MS and its application to forensic cases","volume":"115","author":"Jang","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.05.062_bib0085","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00216-014-8388-1","article-title":"Development and validation of a rapid turboflow LC-MS\/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases","volume":"407","author":"Dolder","year":"2015","journal-title":"Anal. Bioanal. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519300135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519300135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T18:29:01Z","timestamp":1608056941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708519300135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":17,"alternative-id":["S0731708519300135"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.05.062","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of an LC-MS\/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.05.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}